Valerie W. Rusch
0000-0003-2345-6900
Publication & Citation Trends
Publications
0 total
OA12.01 IASLC Mesothelioma Staging Project: Impact of Molecular Alterations on Survival in a Cohort From 9th Edition Database
Cited by 0
Semantic Scholar
OA11.01 Impact of Smoking Status on the Prognosis of Lung Cancer in the IASLC Ninth Edition TNM Classification Database
Cited by 0
Semantic Scholar
OA11.02 Molecular Alterations and Survival: Analyses from IASLC 9th Edition Staging Database
Cited by 0
Semantic Scholar
P2.07C.01 LCMC3: Clinical Utility of Suvmax on Preoperative 18F-FDG PET-CT in Resectable NSCLC Treated with Neoadjuvant Atezolizumab
Cited by 1
Semantic Scholar
MA15.09 LCMC3: Long-Term Disease-Free and Overall Survival and their Association with ctDNA after Neoadjuvant Atezolizumab for NSCLC
Cited by 4
Semantic Scholar
Artificial intelligence-powered assessment of pathologic response to neoadjuvant atezolizumab in patients with non-small cell lung cancer: results from the LCMC3 study.
Cited by 16
Semantic Scholar
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial OA
Cited by 4
Semantic Scholar
MA17.04 The IASLC Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma OA
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(376)
Lung Cancer Diagnosis and Treatment
(335)
Occupational and environmental lung diseases
(249)
Pleural and Pulmonary Diseases
(179)
Medical Imaging and Pathology Studies
(134)
Affiliations
Broad Institute
Dartmouth College
University of Southern California
University of Hawaiʻi at Mānoa
City College of New York